Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling interest
Beginning Balance (in shares) at Dec. 31, 2022		187,280,015
Beginning Balance at Dec. 31, 2022	$ 239,302	$ 187	$ 970,180	$ (732,241)	$ 1,176
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(148,173)			(148,017)	(156)
Issuance of common stock upon vesting of restricted stock units (in shares)		1,762,086
Issuance of common stock upon vesting of restricted stock units	2	$ 2
Forfeitures (in shares)		(90,458)
Equity-based compensation	$ 66,835		66,835
Stock options exercised (in shares)	0
Noncontrolling interest attributable to subsidiary	$ 105				105
Ending Balance (in shares) at Dec. 31, 2023		188,951,643
Ending Balance at Dec. 31, 2023	158,071	$ 189	1,037,015	(880,258)	1,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(128,071)			(128,035)	(36)
Issuance of common stock upon vesting of restricted stock units (in shares)		2,885,424
Issuance of common stock upon vesting of restricted stock units	3	$ 3
Forfeitures (in shares)		(6,270)
Shares withheld related to net restricted stock settlement (in shares)		(69,820)
Shares withheld related to net restricted stock settlement	(350)		(350)
Equity-based compensation	$ 71,132		71,132
Stock options exercised (in shares)	17,662	17,662
Stock options exercised	$ 155		155
Noncontrolling interest attributable to subsidiary	$ 15				15
Ending Balance (in shares) at Dec. 31, 2024	191,778,639	191,778,639
Ending Balance at Dec. 31, 2024	$ 100,955	$ 192	1,107,952	(1,008,293)	1,104
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(978)			(724)	(254)
Issuance of common stock upon vesting of restricted stock units (in shares)		11,277,430
Issuance of common stock upon vesting of restricted stock units	0
Forfeitures (in shares)		(277)
Equity-based compensation	$ 62,082	$ 12	62,070
Stock options exercised (in shares)	1,097,827	1,097,827
Stock options exercised	$ 18,068	$ 1	18,067
Sale of consolidated subsidiary	$ (850)				(850)
Ending Balance (in shares) at Dec. 31, 2025	204,153,619	204,153,619
Ending Balance at Dec. 31, 2025	$ 179,277	$ 205	$ 1,188,089	$ (1,009,017)	$ 0